Deborah Burke
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (55.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 52.8% of the total. 2024 is the largest year on record at $1,717, 3.8 times the $457 reported in 2019.
Across 50 payments — averaging $65.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$2K
- AbbVie$880
- Kyowa Kirin, Inc.$232
- Acadia Pharmaceuticals Inc$67
- EMD Serono, Inc.$52
- GE HealthCare$49
- plus $257 from 10 others
Across 394 payments — averaging $8047.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$675K
- Biogen$659K
- Genentech, Inc.$392K
- Vertex$288K
- AbbVie$174K
- GSK$167K
- plus $816K from 14 others
What the payments were for
- Speaking & faculty fees$361%
- Travel & lodging$1,79055%
- Food & beverage$1,38643%
- Education$401%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 17 | $1,717 |
| AbbVie | 3 | $880 |
| Kyowa Kirin, Inc. | 7 | $232 |
| Acadia Pharmaceuticals Inc | 4 | $67 |
| EMD Serono, Inc. | 2 | $52 |
| GE HealthCare | 3 | $49 |
| Amgen | 2 | $46 |
| Adamas Pharmaceuticals, Inc. | 2 | $37 |
| Acorda Therapeutics, Inc | 2 | $36 |
| Novartis | 2 | $36 |
| MDD US Operations, LLC | 1 | $24 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Eisai Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,253 in reported general payments places this provider in the 55th percentile of 1,434 neurology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 13 | $415 |
| Alendronate Sodium | 12 | $278 |
| Clonazepam | 12 | $206 |
| Levothyroxine Sodium | 13 | $185 |
Paid to pharmacies, not to this prescriber.
Other neurology in Tampa
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Mark CascioneTampa$1.2M
- Tuan VuTampa$1M
- Katherine StandleyTampa$735K
- Susan SteenTampa$341K
- Rossitza ChichkovaTampa$294K
- Brody HenkelTampa$262K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.